RAIA DROGASIL S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.62 BRL | +2.69% |
|
+0.67% | -12.86% |
| Mar. 06 | Transcript : Raia Drogasil S.A., Q4 2023 Earnings Call, Mar 06, 2024 | |
| Mar. 05 | Raia Drogasil S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 36,800 | 41,301 | 40,026 | 39,085 | 50,403 | 43,922 | - | - |
| Enterprise Value (EV) 1 | 37,628 | 42,074 | 41,175 | 44,709 | 57,058 | 50,956 | 51,434 | 51,627 |
| P/E ratio | 67.9 x | 71.4 x | 49.3 x | 39.4 x | - | 30.9 x | 22.9 x | 18.6 x |
| Yield | 0.57% | 0.1% | - | - | - | 1.09% | 1.89% | 2.09% |
| Capitalization / Revenue | 2.1 x | 2.06 x | 1.66 x | 1.34 x | 1.48 x | 1.12 x | 0.98 x | 0.86 x |
| EV / Revenue | 2.15 x | 2.1 x | 1.71 x | 1.54 x | 1.68 x | 1.3 x | 1.14 x | 1.01 x |
| EV / EBITDA | 28 x | 29.4 x | 22.8 x | 19.8 x | 21.9 x | 11.6 x | 9.84 x | 8.47 x |
| EV / FCF | 55.5 x | 52.3 x | 60.3 x | 90.6 x | 119 x | 46.5 x | 39.2 x | 24.7 x |
| FCF Yield | 1.8% | 1.91% | 1.66% | 1.1% | 0.84% | 2.15% | 2.55% | 4.05% |
| Price to Book | 9.14 x | 9.47 x | 8.56 x | 7.32 x | 8.46 x | 6.16 x | 5.37 x | 4.93 x |
| Nbr of stocks (in thousands) | 1,714,103 | 1,715,363 | 1,713,046 | 1,713,657 | 1,714,382 | 1,714,382 | - | - |
| Reference price 2 | 21.47 | 24.08 | 23.37 | 22.81 | 29.40 | 25.62 | 25.62 | 25.62 |
| Announcement Date | 2/19/20 | 3/9/21 | 2/22/22 | 3/7/23 | 3/5/24 | - | - | - |
1BRL in Million2BRL
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 17,503 | 20,067 | 24,127 | 29,067 | 33,974 | 39,244 | 44,993 | 51,232 |
| EBITDA 1 | 1,344 | 1,429 | 1,807 | 2,262 | 2,603 | 4,409 | 5,229 | 6,092 |
| EBIT 1 | 840.6 | 865.3 | 1,180 | 2,262 | 2,603 | 2,451 | 3,129 | 3,773 |
| Operating Margin | 4.8% | 4.31% | 4.89% | 7.78% | 7.66% | 6.25% | 6.95% | 7.36% |
| Earnings before Tax (EBT) 1 | 649.1 | 743.2 | 1,065 | 1,193 | 1,312 | 1,809 | 2,489 | 3,095 |
| Net income 1 | 542.9 | 579.3 | 815.2 | 996.1 | 1,151 | 1,390 | 1,804 | 2,244 |
| Net margin | 3.1% | 2.89% | 3.38% | 3.43% | 3.39% | 3.54% | 4.01% | 4.38% |
| EPS 2 | 0.3161 | 0.3373 | 0.4739 | 0.5788 | - | 0.8282 | 1.119 | 1.375 |
| Free Cash Flow 1 | 678.6 | 804.2 | 683.1 | 493.5 | 480.7 | 1,096 | 1,312 | 2,089 |
| FCF margin | 3.88% | 4.01% | 2.83% | 1.7% | 1.42% | 2.79% | 2.92% | 4.08% |
| FCF Conversion (EBITDA) | 50.5% | 56.27% | 37.8% | 21.81% | 18.47% | 24.85% | 25.1% | 34.29% |
| FCF Conversion (Net income) | 124.99% | 138.83% | 83.8% | 49.54% | 41.77% | 78.8% | 72.76% | 93.1% |
| Dividend per Share 2 | 0.1234 | 0.0231 | - | - | - | 0.2801 | 0.4841 | 0.5353 |
| Announcement Date | 2/19/20 | 3/9/21 | 2/22/22 | 3/7/23 | 3/5/24 | - | - | - |
1BRL in Million2BRL
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 6,165 | 6,474 | 6,563 | 7,179 | 7,490 | 7,836 | 7,931 | 9,025 | 9,288 | 8,924 | 9,609 | 9,825 | 9,979 | 10,249 |
| EBITDA 1 | 446.2 | 448.1 | 388.4 | 727.5 | 546.8 | 599.4 | 563 | 767.6 | 658.1 | 614.5 | 663.3 | - | - | - |
| EBIT 1 | 288.1 | 276.9 | 220.7 | 555.7 | 369.9 | 599.4 | 374.3 | 573 | 453.8 | 614.5 | 550 | 822.8 | 659.5 | 614.9 |
| Operating Margin | 4.67% | 4.28% | 3.36% | 7.74% | 4.94% | 7.65% | 4.72% | 6.35% | 4.89% | 6.89% | 5.72% | 8.37% | 6.61% | 6% |
| Earnings before Tax (EBT) 1 | - | - | 155.1 | - | 272.3 | 292.8 | 203.5 | 446.8 | 344.8 | 304.3 | 308.3 | 536.9 | 442.6 | 485.7 |
| Net income 1 | - | 187.2 | 153.6 | 354.8 | 215.4 | 285.2 | 192.3 | 363.2 | 296.5 | 284.7 | 240.7 | 389.9 | 328.9 | 358.6 |
| Net margin | - | 2.89% | 2.34% | 4.94% | 2.88% | 3.64% | 2.42% | 4.02% | 3.19% | 3.19% | 2.5% | 3.97% | 3.3% | 3.5% |
| EPS 2 | 0.0898 | 0.1368 | 0.0812 | 0.2059 | 0.1252 | 0.1654 | 0.1099 | 0.2028 | 0.1586 | - | 0.1500 | 0.2800 | 0.2200 | 0.2400 |
| Dividend per Share 2 | - | - | - | - | - | - | - | - | - | - | - | 0.1177 | - | 0.1247 |
| Announcement Date | 11/9/21 | 2/22/22 | 5/3/22 | 7/29/22 | 10/31/22 | 3/7/23 | 5/2/23 | 8/8/23 | 10/31/23 | 3/5/24 | - | - | - | - |
1BRL in Million2BRL
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | 827 | 773 | 1,149 | 5,624 | 6,655 | 7,034 | 7,512 | 7,704 |
| Net Cash position 1 | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 0.6157 x | 0.5409 x | 0.6358 x | 2.486 x | 2.556 x | 1.595 x | 1.437 x | 1.265 x |
| Free Cash Flow 1 | 679 | 804 | 683 | 493 | 481 | 1,096 | 1,313 | 2,089 |
| ROE (net income / shareholders' equity) | 14.4% | 13.8% | 17.4% | 19.9% | 18.7% | 21% | 26.1% | 27.8% |
| ROA (Net income/ Total Assets) | 5.54% | 4.61% | 5.51% | 6.23% | 5.66% | 10.1% | 11.3% | - |
| Assets 1 | 9,800 | 12,568 | 14,791 | 15,980 | 20,333 | 13,698 | 15,931 | - |
| Book Value Per Share 2 | 2.350 | 2.540 | 2.730 | 3.120 | 3.470 | 4.160 | 4.770 | 5.200 |
| Cash Flow per Share 2 | 0.5600 | 0.8600 | 0.9000 | 0.9800 | 1.080 | 1.510 | 1.860 | 2.410 |
| Capex 1 | 287 | 673 | 867 | 1,189 | 1,305 | 1,158 | 1,340 | 1,293 |
| Capex / Sales | 1.64% | 3.35% | 3.6% | 4.09% | 3.84% | 2.95% | 2.98% | 2.52% |
| Announcement Date | 2/19/20 | 3/9/21 | 2/22/22 | 3/7/23 | 3/5/24 | - | - | - |
1BRL in Million2BRL
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
25.62
BRL
Average target price
31.01
BRL
Spread / Average Target
+21.03%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -12.86% | 8.57B | |
| +32.95% | 1.32B | |
| +6.76% | 419M | |
| +5.93% | 282M | |
| +10.56% | 224M | |
| -8.26% | 85.07M | |
| +20.94% | 59.57M |
- Stock Market
- Equities
- RADL3 Stock
- Financials Raia Drogasil S.A.
